Latest China Medical System Holdings news, funding rounds and robotics & AI coverage. 1 article tracked by The Robotics Media.
China Medical System Holdings Limited (CMS, HKEX: 0867) is a leading integrated pharmaceutical group headquartered in Shenzhen, Guangdong. Founded in 1995, CMS specializes in the promotion, distribution and clinical translation of innovative drugs across China and Southeast Asia, spanning cardiovascular, dermatology, ophthalmology and central nervous system therapies.
The company has emerged as a key commercialization partner for global biotech innovators and is now deepening its AI-driven R&D through a multi-program collaboration with Insilico Medicine to co-develop novel CNS and autoimmune therapies using Insilico's Pharma.AI platform.